| 25FWT | 25-Foot Walk Test |
| 9HPT | Nine-Hole Peg Test |
| BREMSO | Bayesian Risk Estimate for Multiple Sclerosis at Onset |
| CC | Choriocapillaris |
| CSF | Cerebrospinal Fluid |
| DCP | Deep Capillary Plexus |
| EDSS | Expanded Disability Status Scale |
| FAZ | Foveal Avascular Zone |
| GCIPL | Ganglion Cell Layer–Inner Plexiform Layer |
| INL | Inner Nuclear Layer |
| IPL | Inner Plexiform Layer |
| MRI | Magnetic Resonance Imaging |
| MoCA | Montreal Cognitive Assessment |
| MOGAD | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease |
| MS | Multiple Sclerosis |
| MS-NON | Multiple Sclerosis without Optic Neuritis |
| MS-ON | Multiple Sclerosis with Optic Neuritis |
| NMOSD | Neuromyelitis Optica Spectrum Disorder |
| OCT | Optical Coherence Tomography |
| OCTA | Optical Coherence Tomography Angiography |
| ON | Optic Neuritis |
| OPL | Outer Plexiform Layer |
| PIRA | Progression Independent of Relapse Activity |
| pwMS | Patients with Multiple Sclerosis |
| RNFL | Retinal Nerve Fiber Layer |
| RoAD | Risk of Ambulatory Disability Score |
| RRMS | Relapsing–Remitting Multiple Sclerosis |
| SCP | Superficial Capillary Plexus |
| SDMT | Symbol Digit Modalities Test |
| VD | Vessel Density |